Phase 1 Chronic Hepatitis C Clinical Trials

2 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–2 of 2 trials

Recruiting

Phase 1

A Randomized, Double-blind, Placebo-controlled, First-in-human, 3-Part Study of Orally Administered ALS-002158 to Evaluate the Safety, Tolerability and Pharmacokinetics of Single Ascending Dosing and Food-effect in Healthy Volunteers, and Multiple Ascending Dosing in Subjects with Chronic Hepatitis C Genotype 1 Infection.

Chronic Hepatitis C infection

CPR Pharma Services78 enrolled4 locationsACTRN12612000176864

Terminated

Phase 1

A phase Ib study of oglufanide disodium (IM862) in patients with chronic HCV infection

Chronic Hepatitis C

Implicit Bioscience Pty Ltd32 enrolled1 locationACTRN12606000505505